Skip to content

Translational study of metabolic profiling in early diagnosis of renal cell carcinoma

Translational study of metabolic profiling in early diagnosis of renal cell carcinoma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064611
Enrollment
Unknown
Registered
2022-10-12
Start date
2022-10-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal cell carcinoma

Interventions

Sponsors

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Subjects volunteered to participate in the study, provided signed and dated written informed consent prior to any study-specific procedures, sampling, and analysis, had good compliance, and cooperated with follow-up; 2. Age >=30 years and =2*10^9/L; 3) HB 90 g/L or higher; 4) The ANC acuity 1.5*10^9/L; 5) PLT acuity 100*10^9/L; (2) Without functional organic disease, the following criteria must be met: 1) T-bil 30ml/min (cockcroft-gault formula); 5) International normalized ratio (INR), activated partial thromboplastin time (aPTT): =60mL/min according to cockcroft-gault formula.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of malignant tumors other than renal cell carcinoma; 2. Patients with postoperative pathological non-renal cell carcinoma.

Design outcomes

Primary

MeasureTime frame
Metabolic phenotype;

Countries

China

Contacts

Public ContactZhai Wei

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine

jackyzw2007@163.com+86 18701771959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026